ACGME Milestones 2.0: why and what's new for cytopathology?

Ritu Nayar*, Scott Anderson, Kathryn S. Dyhdalo, Laura Edgar, Kate Hatlak, Evita Henderson-Jackson, Sydney McLean, Matthew W. Rosenbaum, Frida Rosenblum, Wesley Y. Naritoku

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Background: Primary stakeholders in the Accreditation Council for Graduate Medical Education (ACGME) Milestones Project are: ACGME, Residency Programs, Residents, Fellowship Programs, Fellows, and Certification Boards. The intent of the Milestones is to describe the educational and professional developmental trajectory of a trainee from the first stages of their postgraduate education through the completion of their clinical training. The Milestones 2.0 project includes changes made based on experience with Milestones 1.0. Methods: The ACGME solicited volunteers to participate in the development of subspecialty Milestones 2.0. The workgroup was charged with reviewing/making any additions to the four “Harmonized Milestones”, developing subspecialty specific milestones for the Patient Care and Medical Knowledge competencies, and creating a supplemental guide. The Milestones were finalized following review of input from an open comment period. Results: The Cytopathology Milestones 2.0 will go into effect July 2021. They include additional subcompetencies in the 4 harmonized competency areas and cytopathology-specific edits to the patient care and medical knowledge subcompetencies. Although the number of subcompetencies has increased from 18 to 21, within each subcompetency, the number of milestone trajectories has decreased. Additionally, within each subcompetency, the wording has been streamlined. A supplemental guide was created and Milestones 1.0 were compared to 2.0; however, curriculum mapping has been left to programs to develop. Conclusions: The ultimate goal of the Cytopathology Milestones 2.0 is to provide better real-time documentation of the progress of cytopathology fellows. The expected outcome is to produce highly competent cytopathologists, improving the care they provide, regardless of the program at which they trained.

Original languageEnglish (US)
Pages (from-to)485-494
Number of pages10
JournalJournal of the American Society of Cytopathology
Issue number5
StatePublished - Sep 1 2021


  • CCC
  • Cytopathology
  • Evaluation
  • Fellowship
  • Milestones

ASJC Scopus subject areas

  • Pathology and Forensic Medicine


Dive into the research topics of 'ACGME Milestones 2.0: why and what's new for cytopathology?'. Together they form a unique fingerprint.

Cite this